You are here

Article info

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy

Authors

  • Hannan Gao Medical Isotopes Research Center and Department of Radiation Medicine, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University, Beijing, China PubMed articlesGoogle scholar articles
  • Yue Wu Medical Isotopes Research Center and Department of Radiation Medicine, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University, Beijing, China PubMed articlesGoogle scholar articles
  • Jiyun Shi Key Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Xin Zhang Medical Isotopes Research Center and Department of Radiation Medicine, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University, Beijing, China PubMed articlesGoogle scholar articles
  • Tianyu Liu Medical Isotopes Research Center and Department of Radiation Medicine, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University, Beijing, China PubMed articlesGoogle scholar articles
  • Biao Hu Medical Isotopes Research Center and Department of Radiation Medicine, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University, Beijing, China PubMed articlesGoogle scholar articles
  • Bing Jia Medical Isotopes Research Center and Department of Radiation Medicine, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University, Beijing, China PubMed articlesGoogle scholar articles
  • Yakun Wan Shanghai Novamab Biopharmaceuticals Co., Ltd, Shanghai, China PubMed articlesGoogle scholar articles
  • Zhaofei Liu Medical Isotopes Research Center and Department of Radiation Medicine, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University, Beijing, China PubMed articlesGoogle scholar articles
  • Fan Wang Medical Isotopes Research Center and Department of Radiation Medicine, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University, Beijing, China Key Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, China PubMed articlesGoogle scholar articles

Citation

Gao H, Wu Y, Shi J, et al
Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy
Journal for ImmunoTherapy of Cancer 2020;8:e001156. doi: 10.1136/jitc-2020-001156
Online issue publication 
November 17, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.